By Tyler Durden
Update (1008ET): Reuters reports BioNTech, Pfizer is expecting laboratory results of the recently discovered Nu variant in two weeks.
“We understand the concern of experts and have immediately initiated investigations on variant B.1.1.529,” BioNTech said.
“We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,” it added.
Reuters notes, “escape variants are virus versions that elude the targeted immune response brought about by vaccination.”
Citi analyst Andrew Baum was the first to note that it could take Pfizer, BioNTech upwards of 100 days to develop a new vaccine to combat Nu.
Pfizer and BioNTech confirmed the redesigned timeline of the new vaccine…
